| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gastrointestinal Research Laboratory (151M2), Veterans Administration Medical Center, San Francisco, California 94121, and the Department of Medicine, University of California, San Francisco, San Francisco, California 94143 [N. W. T., T. L. S., J. R. G., S. B. H., Y. S. K.]; Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010 [J. E. S.]; and Division of Hematology/Oncology, University Hospitals of Cleveland, Cleveland, Ohio 44106 [J. K. V. W.]
Sodium butyrate induces morphological and biochemical changes consistent with a more differentiated phenotype in some colon cancer cell lines. These changes include increased expression of carcinoembryonic antigen (CEA) and other oncodevelopmental markers. We utilized domain-specific probes and polyclonal antibodies against CEA-related antigens to study sodium butyrate-induced expression of the CEA gene family in a villous adenoma-derived cell line, which is nontumorigenic in nude mice (VACO 235), and two colonic carcinoma cell lines known to respond to sodium butyrate exposure by phenotypic differentiation (HT-29 and LS 174T). The induction begins as quickly as 24 h after exposure and occurs primarily at a transcriptional level, although some translational control is also evident. No evidence was found for gene amplification, rearrangement, or methylation to account for the mechanism of this transcriptional control. [35S]Cysteine pulse-labeled cell lysate immunoblots and polyadenylated RNA blot hybridization suggest that increases in mRNA transcript and CEA-related glycoprotein levels are primarily due to increased synthesis rather than decreased degradation. A considerable amount of heterogeneity is seen in the biosynthesis of the CEA-related glycoproteins, with each cell line showing a distinct pattern of CEA-related antigen expression from a limited number of mRNA transcripts.
1 This work was supported by the Veterans Administration Medical Research Service; NIH Institutional Training Grant 5 T32 DK07007; American Cancer Society Grant PDT-293; and National Cancer Institute Grants CA45967, CA47551, and CA37808. N. W. T. is an Associate Investigator of the Veterans Administraiton, and Y. S. K. is a Medical Investigator of the Veterans Administration.
2 To whom requests for reprints should be addressed, at G. I. Research Laboratory (151M2), Veterans Administration Medical Center, 4150 Clement St., San Francisco, CA 94121.
Received 9/ 2/88. Revised 3/ 1/89. Accepted 3/22/89.
This article has been cited by other articles:
![]() |
M. Li, R. Vemulapalli, A. Ullah, L. Izu, M. E. Duffey, and P. Lance Downregulation of a human colonic sialyltransferase by a secondary bile acid and a phorbol ester Am J Physiol Gastrointest Liver Physiol, March 1, 1998; 274(3): G599 - G606. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ranganna and F. M. Yatsu Inhibition of Platelet-Derived Growth Factor BB–Induced Expression of Glyceraldehyde- 3-Phosphate Dehydrogenase by Sodium Butyrate in Rat Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3420 - 3427. [Abstract] [Full Text] |
||||
![]() |
K. Ranganna, T. Joshi, and F. M. Yatsu Sodium Butyrate Inhibits Platelet-Derived Growth Factor–Induced Proliferation of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2273 - 2283. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |